MindMed Board Battle Continues with Competing Shareholder Bids

May 5, 2023 · Green Market Report

Both parties accused each other of not understanding FDA processes.

After psychedelic drug company Mind Medicine (Nasdaq: MNMD) released a detailed letter to shareholders pushing back against an attempted board coup by a company called FCM MM Holdings, FCM responded with its own letter to shareholders accusing the current board of botching the company’s strategy as well as other misdeeds.

FCM MM Holdings and its affiliates beneficially own 1,368,538 common shares of MindMed Inc., representing approximately 3.5% of the outstanding common shares.

MindMed released its letter alongside its earnings earlier this week.

FCM’s letter notes that MindMed’s stock valuation has plunged 95%, while the executive team awarded itself with lavish compensation. It’s worth noting that the PSYK ETF is down 22% for the past year and the Horizons Psychedelic Stock ETF is down 42% for the past year.

FCM says that the board only spent 12.7% of its funds on operating costs for the company’s drugs and 31.8% on compensation. It also accuses the board of only owning 0.22% of the company’s shares, which it claims to be smaller than most boards’ average.

The FCM letter suggests that its suggested board members would cut unnecessary expenses and save the company $4.5 million. It also wants to proceed with a Phase 3 study of MM-120. The group believes that the company is pursuing a Phase 2b dose finding study that is flawed and unnecessary. The current MindMed board stated it can’t proceed to the Phase 3 study without completing this Phase 2b study.

The letter also claims that the current board doesn’t have experience with the FDA process, which the current board has accused the FCM team of as well.

The FCM team did disclose it has met with the current MindMed team but hasn’t gotten the response it had hoped for.

“Since 2021, we have attempted to engage constructively with the Board on our ideas for adding value for the benefit of all MindMed shareholders, including our Value Enhancement Plan that we presented to the Board and management in August 2022,” the letter read. “We remain dumbstruck by the Board’s lack of urgency in addressing the critical issues we raised with them. Unfortunately, we had to take the extraordinary step of nominating four highly qualified director candidates because FCM determined that the only way to put MindMed back on track and stop the destruction of further shareholder value would be to reconstitute the Board and take immediate action for the benefit of all shareholders.” (Full Story)

In categories:Business Psychedelics
Next Post

Connecting Cannabis Brands and Consumers: The Future of Brand Discovery

THE CANNABIS INDUSTRY has been rapidly expanding in recent years, with legal status and widespread acceptance paving the way for significant growth and diversification. As the industry evolves, the role of technology in connecting cannabis brands directly with consumers is becoming increasingly important.…
Read
Previous Post

The $300,000,000 Club - Which 5 States Collected over $300 Million in Cannabis Tax Revenue Last Year Alone?

A recent report from the Marijuana Policy Project revealed that tax revenue from adult-use cannabis experienced a decline across legal states in 2022, marking the first time this has occurred in the United States. While sales tax from cannabis still generated a respectable…
Read
Random Post

No Federal Legalization, No Problem -$71,000,000,000 in Legal Cannabis by 2030 Says NFD?

Gary Allen, CEO of New Frontier Data, announced the release of the 2023 U.S. Cannabis Report: Market Updates & Projections, which provides insights into the current and future state of the American cannabis market. The report is sponsored by Cannacare Docs…
Read
Random Post

A Seat on the Titanic? - California Cannabis Sales Dropped in 2022 for the First Time Ever Since Legalization

California, an industry bellwether for the marijuana industry, is seeing signs of contraction For the first time since the state's adult-use market opened five years ago, annual sales for marijuana in California fell in 2022. While Colorado and Oregon dispensaries are now…
Read
Random Post

Cannabis: It’s What’s For Christmas

There was a time in most of our young lives when the heady few weeks between Thanksgiving and Christmas were spent compiling a list of all the fiendish new toys we wanted Santa to bring us. The idea that some…
Read
Random Post

At least 10 fake unions identified in California marijuana industry

At least 10 “labor organizations” that experts and observers have flagged as suspicious – and share characteristics in common with another “union” that state regulators declared fake in July – are signing required labor agreements with licensed California marijuana businesses,…
Read